Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAD001 (Everolimus) in Advanced Cholangiocarcinoma
NCT01525719Phase 2Unknown
- Sponsor
- Rajavithi Hospital
- Start
- Jan 2012
- Primary completion
- Dec 2013
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of everolimus in cholangiocarcinoma (CCA), sponsored by Rajavithi Hospital. Status: unknown.
02
Drugs
everolimus
03
Conditions
cholangiocarcinoma (CCA)
Beyond the preview
Go deeper on NCT01525719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01525719.